Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 Inhibitors
Peptidyl-prolyl <i>cis/trans</i> isomerase Pin1 plays a key role in amplifying and translating multiple oncogenic signaling pathways during oncogenesis. The blockade of Pin1 provided a unique way of disrupting multiple oncogenic pathways and inducing apoptosis. Aiming to develop potent P...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/7/1198 |
id |
doaj-933447aac5ab451a9e3a759afb3fbe4e |
---|---|
record_format |
Article |
spelling |
doaj-933447aac5ab451a9e3a759afb3fbe4e2020-11-24T20:42:10ZengMDPI AGMolecules1420-30492019-03-01247119810.3390/molecules24071198molecules24071198Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 InhibitorsShuxiang Wang0Lihong Guan1Jie Zang2Kun Xing3Jian Zhang4Dan Liu5Linxiang Zhao6Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaPeptidyl-prolyl <i>cis/trans</i> isomerase Pin1 plays a key role in amplifying and translating multiple oncogenic signaling pathways during oncogenesis. The blockade of Pin1 provided a unique way of disrupting multiple oncogenic pathways and inducing apoptosis. Aiming to develop potent Pin1 inhibitors, a series of benzimidazole derivatives were designed and synthesized. Among the derivatives, compounds <b>6h</b> and <b>13g</b> showed the most potent Pin1 inhibitory activity with IC<sub>50</sub> values of 0.64 and 0.37 μM, respectively. In vitro antiproliferative assay demonstrated that compounds <b>6d</b>, <b>6g</b>, <b>6h</b>, <b>6n</b>, <b>6o</b> and <b>7c</b> exhibited moderate antiproliferative activity against human prostate cancer PC-3 cells. Taken together, these unique benzimidazole derivatives exhibited great potential to be further explored as potent Pin1 inhibitors with improved potency.https://www.mdpi.com/1420-3049/24/7/1198Pin1 inhibitorsbenzimidazole derivativesantiproliferative activity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shuxiang Wang Lihong Guan Jie Zang Kun Xing Jian Zhang Dan Liu Linxiang Zhao |
spellingShingle |
Shuxiang Wang Lihong Guan Jie Zang Kun Xing Jian Zhang Dan Liu Linxiang Zhao Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 Inhibitors Molecules Pin1 inhibitors benzimidazole derivatives antiproliferative activity |
author_facet |
Shuxiang Wang Lihong Guan Jie Zang Kun Xing Jian Zhang Dan Liu Linxiang Zhao |
author_sort |
Shuxiang Wang |
title |
Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 Inhibitors |
title_short |
Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 Inhibitors |
title_full |
Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 Inhibitors |
title_fullStr |
Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 Inhibitors |
title_full_unstemmed |
Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 Inhibitors |
title_sort |
structure-based design of novel benzimidazole derivatives as pin1 inhibitors |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2019-03-01 |
description |
Peptidyl-prolyl <i>cis/trans</i> isomerase Pin1 plays a key role in amplifying and translating multiple oncogenic signaling pathways during oncogenesis. The blockade of Pin1 provided a unique way of disrupting multiple oncogenic pathways and inducing apoptosis. Aiming to develop potent Pin1 inhibitors, a series of benzimidazole derivatives were designed and synthesized. Among the derivatives, compounds <b>6h</b> and <b>13g</b> showed the most potent Pin1 inhibitory activity with IC<sub>50</sub> values of 0.64 and 0.37 μM, respectively. In vitro antiproliferative assay demonstrated that compounds <b>6d</b>, <b>6g</b>, <b>6h</b>, <b>6n</b>, <b>6o</b> and <b>7c</b> exhibited moderate antiproliferative activity against human prostate cancer PC-3 cells. Taken together, these unique benzimidazole derivatives exhibited great potential to be further explored as potent Pin1 inhibitors with improved potency. |
topic |
Pin1 inhibitors benzimidazole derivatives antiproliferative activity |
url |
https://www.mdpi.com/1420-3049/24/7/1198 |
work_keys_str_mv |
AT shuxiangwang structurebaseddesignofnovelbenzimidazolederivativesaspin1inhibitors AT lihongguan structurebaseddesignofnovelbenzimidazolederivativesaspin1inhibitors AT jiezang structurebaseddesignofnovelbenzimidazolederivativesaspin1inhibitors AT kunxing structurebaseddesignofnovelbenzimidazolederivativesaspin1inhibitors AT jianzhang structurebaseddesignofnovelbenzimidazolederivativesaspin1inhibitors AT danliu structurebaseddesignofnovelbenzimidazolederivativesaspin1inhibitors AT linxiangzhao structurebaseddesignofnovelbenzimidazolederivativesaspin1inhibitors |
_version_ |
1716823007300681728 |